POINT Biopharma Global Inc

PNTStocksBiotechnologyUnited StatesNasdaqUSD

Price

$12.50

Today

+0.0%

YTD

+0.2%

About

POINT Biopharma Global Inc. is a prominent pharmaceutical company specialising in the development of innovative radioligand therapies targeted at treating cancer. The company operates globally, striving to improve patients' lives through advanced technology. As part of the biopharmaceutical sector, POINT Biopharma Global Inc. plays a crucial role in creating advanced therapeutics that leverage biologic functions. Its primary service includes developing radioisotopes for use in targeted cancer therapy. POINT uses medical isotopes including lutetium, fluorine, actinium and gallium. Diversify your virtual portfolio by following PNT shares on eToro.

Price chart

Closing price history for PNT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)13.97

P/S (TTM)5.43

P/B (TTM)3.12

Market cap$1.33B

Cap tierSmall-cap

Industry avg P/E-6.22

Profitability

Gross margin98.93%

EBIT margin44.23%

Net margin-887.97%

ROE26.33%

ROA24.04%

Earnings & Revenue

Revenue (TTM)$243.69M

Revenue growth (1Y)Unknown

EPS (TTM)$0.89

Free cash flow$92.74M

Total debt$10.66M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.89

Employees129

Next earnings25 Mar '24

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.